Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Stock Information for Gran Tierra Energy Inc.

Loading

Please wait while we load your information from QuoteMedia.